Frankfurt - Delayed Quote EUR

Natural Alternatives International, Inc. (NA2.F)

2.2400

-0.0400

(-1.75%)

At close: April 17 at 9:50:05 PM GMT+2

Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination

CARLSBAD, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands today announced the publication of positive clinical trial results in the journal Food Hydrocolloids for Health showing that TriBsyn™ supplementation led to significantly greater bioavailability and efficiency of beta-alanine along with the elimination of paresthesia, a common beta-alanine side effect. Study Highlights: TriBsyn™ is an encapsulated low-dose β-alanine complex.Tr

GlobeNewswire last month

NAII
Natural Alternatives International First Quarter 2025 Earnings: US$0.34 loss per share (vs US$0.12 loss in 1Q 2024)

Natural Alternatives International ( NASDAQ:NAII ) First Quarter 2025 Results Key Financial Results Revenue: US$33.2m...

Simply Wall St. 4 months ago

NAII
Natural Alternatives International, Inc. Announces 2025 Q1 Results

CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.0 million, or $0.33 per diluted share, on net sales of $33.2 million for the first quarter of fiscal year 2025 compared to a net loss of $0.7 million, or $0.12 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months en

GlobeNewswire 5 months ago

NAII
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution partnership with B&D Nutritional Ingredients, Inc., a renowned raw material distributor in the dietary supplement industry since 1993. This strategic partnership took effect on October 1st, 2024. Under the terms of the agreement, B&D will distribute NAI’s newly introduced carnosine booster, TriBsyn™, to

GlobeNewswire 5 months ago

NAII
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results

CARLSBAD, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.9 million, or ($0.32) per diluted share, on net sales of $29.5 million for the fourth quarter of fiscal year 2024 compared to a net income of $2.0 million, or $0.35 per diluted share, in the fourth quarter of the prior fiscal year. Net sales during the three mo

GlobeNewswire 6 months ago

NAII
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism

CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024 offers a unique platform for companies to present and educate on innovative science in clinical nutrition and metabolism, fostering collaboration with physicians, dietitians, pharmacists, nutritionists, scientists, and nurses. The NAI and CarnoSyn® Bran

GlobeNewswire 7 months ago

NAII
CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”

CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology to increase beta-alanine bioavailability and absorption while effectively eliminating beta-alanine related paresthesia. The proprietary TriBsyn™ formulation successfully removes the common paresthesia sensation

GlobeNewswire 8 months ago

NAII
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results

CARLSBAD, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.6 million, or ($0.27) per diluted share, on net sales of $25.1 million for the third quarter of fiscal year 2024 compared to a net loss of $2.4 million, or ($0.41) per diluted share, in the third quarter of the prior fiscal year. Net sales during the three months

GlobeNewswire 10 months ago

NAII

Performance Overview

Return	NA2.F	S&P 500 (^GSPC)
YTD	-44.28%	-10.18%
1-Year	-62.35%	+5.19%
3-Year	-75.78%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Natural Alternatives International, Inc. (NA2.F)

Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination

Natural Alternatives International First Quarter 2025 Earnings: US$0.34 loss per share (vs US$0.12 loss in 1Q 2024)

Natural Alternatives International, Inc. Announces 2025 Q1 Results

CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results

CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism

CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder”

Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results

Performance Overview